09 December 2022 : Original article
Modification of Venous Outflow to Avoid Thrombotic Graft Failure in Pancreas Transplantation
Je Ho Ryu1ABE, Jae Ryong Shim1ABC, Tae Beom Lee1BCD, Kwangho Yang1ADE, Taeun Kim2ABF, Seo Rin Kim 3EF, Byunghyun Choi1ABCDEF*DOI: 10.12659/AOT.937514
Ann Transplant 2022; 27:e937514
Table 1 Baseline characteristics of pancreas transplant recipients.
Vena cava group (n=31) | Aorta group (n=28) | p-value | |
---|---|---|---|
Age, yr (SD) | 39.1 (11.8) | 42.0 (13.1) | 0.376 |
Female gender, n (%) | 18 (58.1) | 11 (39.3) | 0.195 |
Body mass index, Kg/m (SD) | 22.2 (2.4) | 22.4 (2.8) | 0.779 |
Preoperative HbA1c (%) (SD) | 8.5 (1.8) | 9.0 (2.9) | 0.466 |
Type I diabetes, n (%) | 22 (71.0) | 18 (64.3) | 0.781 |
Donor Age, y (SD) | 28.3 (3.7) | 28.5 (8.8) | 0.943 |
Donor female gender, n (%) | 7 (22.6) | 10 (35.7) | 0.390 |
Donor body mass index, Kg/m (SD) | 23.3 (3.7) | 23.1 (4.0) | 0.868 |
Donor HbA1c (%) (SD) | 5.3 (0.3) | 5.3 (0.3) | 0.422 |
Cold ischemic time, minute (SD) | 308.2 (61.2) | 277.8 (51.8) | 0.045 |
PDRI (SD) | 1.26 (0.37) | 1.22 (0.31) | 0.660 |
Transplant type, n (%) | 0.828 | ||
SPK | 3 (9.7) | 3 (10.7) | |
SPLK | 4 (12.9) | 5 (17.9) | |
PAK | 7 (22.6) | 8 (28.6) | |
PTA | 17 (54.8) | 12 (42.9) | |
Re-transplant, n (%) | 2 (6.5) | 3 (10.7) | 0.661 |
* PDRI – pancreas donor risk index; SPLK – simultaneous cadaveric pancreas and living donor kidney transplant. |